Propensity for non-alcoholic fatty liver disease: More evidence for ethnic susceptibility

Liver International

Volumn 29, Issue 1, 2009, Pages 4-5

  Harmon, R Christopher ^a   Caldwell, Stephen H ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN;

AFRICAN AMERICAN; ALCOHOL CONSUMPTION; BODY FAT DISTRIBUTION; BODY MASS; DISEASE ASSOCIATION; ECHOGRAPHY; EDITORIAL; ENERGY METABOLISM; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HISPANIC; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PREVALENCE; SOUTH AMERICA;

AGE FACTORS; ALANINE TRANSAMINASE; BODY MASS INDEX; FATTY LIVER; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; PREVALENCE; SOUTH AMERICA;

EID: 57749200733     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01959.x     Document Type: Editorial

References (20)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006; 43(Suppl.): S99-112.
2. Verma S, Bonacini M, Govindarajan S, et al. More advanced hepatic fibrosis in Hispanics with chronic hepatitis C infection: Role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol 2006; 101: 1817-23.
3. Caldwell SH, Harris DM, Hespenheide EE. Is NASH under diagnosed among African Americans?. Am J Gastroenterol 2002; 97: 1496-500.
4. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-9.
5. Weston SR, Leyden W, Murphy R, et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005; 41: 372-9.
6. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387-95.
7. Riquelme A, Arrese M, Soza A, et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 2008; 29: 83-89.
8. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-9.
9. Sadeeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.
10. Browning JD, Kumar KS, Saboorian MH, Thiele DL. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 2004; 99: 292-8.
11. Perry AC, Applegate EB, Jackson ML, et al. Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables. J Appl Physiol 2000; 89: 636-43.
12. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005; 165: 1395-400.
13. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 2005; 41: 426-9.
14. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115: 561-5.
15. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-16.
16. Caldwell SH, Ikura Y, Iezzoni JC, Liu Z. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? J Gastroenterol and Hepatol 2007; 22: S11-9.
17. Neel JV. Diabetes mellitus: A 'thrifty'genotype rendered detrimental by 'progress'? Am J Hum Genet 1962; 14: 353-62.
18. Hurley BF, Nemeth PM, Martin WHD, et al. Muscle triglyceride utilization during exercise: Effect of training. J Appl Physiol 1986; 60: 562-7.
19. Stannard SR, Johnson NA. Insulin resistance and elevated triglyceride in muscle: More important for survival than 'thrifty'genes? J Physiol 2004; 554: 595-607.
20. Moestrup SK, Nielson LB. The role of the kidney in lipid metabolism. Curr Opin Lipid 2005; 16: 301-6.